These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31836833)

  • 1. Comment on: 'You've got dry macular degeneration, end of story: a qualitative study into the experience of living with non-neovascular age-related macular degeneration'.
    Gandhi JS
    Eye (Lond); 2020 Oct; 34(10):1935-1936. PubMed ID: 31836833
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Comment on: 'You have got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration'.
    Taylor DJ; Jones L; Binns AM; Crabb DP
    Eye (Lond); 2020 Oct; 34(10):1937-1938. PubMed ID: 31836834
    [No Abstract]   [Full Text] [Related]  

  • 3. 'You've got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration.
    Taylor DJ; Jones L; Binns AM; Crabb DP
    Eye (Lond); 2020 Mar; 34(3):461-473. PubMed ID: 31118490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: 'You've got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration.
    Taylor DJ; Jones L; Binns AM; Crabb DP
    Eye (Lond); 2020 Mar; 34(3):603. PubMed ID: 31488885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of neovascular age-related macular degeneration and geographic atrophy in Denmark.
    Sedeh FB; Scott DAR; Subhi Y; Sørensen TL
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipids in adults with late age-related macular degeneration: a case-control study.
    Semba RD; Moaddel R; Cotch MF; Jonasson F; Eiriksdottir G; Harris TB; Launer LJ; Sun K; Klein R; Schaumberg DA; Jónsson P; Gudnason V; Ferrucci L
    Lipids Health Dis; 2019 Jan; 18(1):7. PubMed ID: 30621701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the anatomical classification of the neovascular form of age-related macular degeneration.
    Gallego-Pinazo R; Monje-Fernández L; García-Marín N; Andreu-Fenoll M; Dolz-Marco R
    Arch Soc Esp Oftalmol; 2017 Feb; 92(2):71-77. PubMed ID: 27378456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Macular Degeneration: Not So Wet and Dry.
    Guymer RH
    Ophthalmol Retina; 2020 Mar; 4(3):249. PubMed ID: 32151345
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'.
    Nestel AR
    Eye (Lond); 2018 Feb; 32(2):477-479. PubMed ID: 29026187
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to: 'Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'.
    Almuhtaseb H; Lotery A
    Eye (Lond); 2018 Feb; 32(2):479-481. PubMed ID: 29052610
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photobiomodulation in dry age-related macular degeneration.
    Uparkar M; Kaul S; Rajput P; Baile R
    Acta Ophthalmol; 2018 Feb; 96(1):e92. PubMed ID: 29164805
    [No Abstract]   [Full Text] [Related]  

  • 13. An update of treatment options for neovascular age-related macular degeneration.
    Iu LP; Kwok AK
    Hong Kong Med J; 2007 Dec; 13(6):460-70. PubMed ID: 18057435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents.
    Gemenetzi M; Lotery AJ; Patel PJ
    Eye (Lond); 2017 Jan; 31(1):1-9. PubMed ID: 27716750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on geographic atrophy in age-related macular degeneration.
    Biarnés M; Monés J; Alonso J; Arias L
    Optom Vis Sci; 2011 Jul; 88(7):881-9. PubMed ID: 21532519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Issue of End Point Discordance in Dry Age-Related Macular Degeneration: How Might Clinical Trials Demonstrate a Functional Benefit?
    Lad EM; Chakravarthy U
    Ophthalmology; 2023 Sep; 130(9):890-892. PubMed ID: 37278678
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic treatment of atrophic age-related macular degeneration.
    Mata NL; Vogel R
    Curr Opin Ophthalmol; 2010 May; 21(3):190-6. PubMed ID: 20216419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegcetacoplan (Syfovre) for geographic atrophy in age-related macular degeneration.
    Med Lett Drugs Ther; 2023 Apr; 65(1673):49-50. PubMed ID: 37020339
    [No Abstract]   [Full Text] [Related]  

  • 19. VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Zanzottera EC; Ach T; Huisingh C; Messinger JD; Freund KB; Curcio CA
    Retina; 2016 Dec; 36 Suppl 1(Suppl 1):S26-S39. PubMed ID: 28005661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry Age-Related Macular Degeneration Pharmacology.
    Wright CB; Ambati J
    Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.